Results
1 -
10 of
20Differential effects of putative lipoxygenase inhibitors on arachidonic acid metabolism in cell-free and intact cell preparations, Inflammation In vitro effects of the antiallergy compound, CI-949, on interleukin-1 and 2 release, and on mitogen and alloantigen responsiveness, Agents and Actions The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation, Agents and Actions Reversal of High dietary fructose-induced PPAR?? suppression by oral administration of lipoxygenase/cyclooxygenase inhibitors, Nutrition & Metabolism Leukotrienes in Lymphocyte Activation: Leukotriene B4 Enhances Interleukin 2 and Interferon-Gamma Production by Mitogen and Alloantigen-Stimulated Human T Cells, Lipid Mediators in the Immunology of Shock Regulation of T-Cell Activation by Leukotriene B4, Lipid Mediators in the Immunology of Shock Leukotrienes in Human and Experimental Ulcerative Colitis, Neuroendocrinology of Gastrointestinal Ulceration Die Bedeutung der Leukotriene in der Pathogenese der multiplen Sklerose und der experimentellen autoimmunen Enzephalomyelitis, Verhandlungen der Deutschen Gesellschaft f??r Neurologie Thein vivo antiinflammatory effects of (E)-2,6-bis(1,1-dimethylethyl)-4-[2-(5-methyl-1H-pyrazol-3-yl) ethenyl]phenol (PD 127443) a novel dual inhibitor of 5-lipoxygenase and cyclooxygenase, Agents and Actions In vitro pharmacology of BAY X1005, a new inhibitor of leukotriene synthesis, Agents and Actions